BioCryst Q3 2026 revenue rises and total revenue guidance is raised
FROM THE WIRE · GLOBENEWSWIRE.COM
— Total net revenue of $180.3 million and ORLADEYO ® net revenue of $174.8 million — — Operating profit of $53.3 million and Non-GAAP operating profit of $86.5 million — — Maintained Full Year 2026 ORLADEYO revenue guidance of $625 to $645 million and increased total revenue…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishRaised total revenue guidance is a positive signal for the company.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Total net revenue was $180.3 million, with ORLADEYO at $174.8 million.
- 02Total revenue guidance for 2026 was increased to $715 to $730 million.
- 03ORLADEYO full-year 2026 revenue guidance was maintained at $625 to $645 million.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets